Cargando…
Long-Term Efficacy and Safety of Partial Splenic Embolization in Hepatocellular Carcinoma Patients with Thrombocytopenia Who Underwent Transarterial Chemoembolization
BACKGROUND: Performing transarterial chemoembolization (TACE) is difficult with the occurrence of thrombocytopenia in cirrhotic patients with hepatocellular carcinoma (HCC). We aimed to evaluate the long-term efficacy and safety of partial splenic embolization (PSE) combined with TACE in patients wi...
Autores principales: | Kim, Nam Hee, Kim, Hong Joo, Cho, Yong Kyun, Hong, Hyun Pyo, Kim, Byung Ik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676001/ https://www.ncbi.nlm.nih.gov/pubmed/31373186 http://dx.doi.org/10.3346/jkms.2019.34.e208 |
Ejemplares similares
-
Partial Splenic Embolization with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma Accompanied by Thrombocytopenia
por: Ooka, Yoshihiko, et al.
Publicado: (2014) -
Effect of partial splenic embolization on transarterial chemoembolization for hepatocellular carcinoma with hypersplenism
por: Liu, Jibing, et al.
Publicado: (2021) -
Effect of acute kidney injury on the patients with hepatocellular carcinoma undergoing transarterial chemoembolization
por: Sohn, Won, et al.
Publicado: (2020) -
Partial splenic embolization for refractory thrombocytopenia
por: Best, Irwin M.
Publicado: (2011) -
Impact of alcohol consumption on treatment outcome of hepatocellular carcinoma patients with viral hepatitis who underwent transarterial chemoembolization
por: Rattanasupar, Attapon, et al.
Publicado: (2022)